CHST5
Carbohydrate sulfotransferase 5
Also known as: CHST5_HUMAN, FLJ22167, I-GLCNAC-6-ST
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZS9
- Gene
- CHST5
- Ensembl
- ENSG00000135702
- Chromosome
- 16
- Canonical length
- 411 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
The protein encoded by this gene belongs to the Gal/GalNAc/GlcNAc 6-O-sulfotransferase (GST) family, members of which catalyze the transfer of sulfate to position 6 of galactose (Gal), N-acetylgalactosamine (GalNAc), or N-acetylglucosamine (GlcNAc) residues within proteoglycans, and sulfation of O-linked sugars of mucin-type acceptors. Carbohydrate sulfation plays a critical role in many biologic processes. This gene is predominantly expressed in colon and small intestine. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
411 residues, UniProt reviewed canonical sequence.
>Q9GZS9|CHST5
1 MGMRARVPKV AHSTRRPPAA RMWLPRFSSK TVTVLLLAQT TCLLLFIISR PGPSSPAGGE
61 DRVHVLVLSS WRSGSSFLGQ LFSQHPDVFY LMEPAWHVWT TLSQGSAATL HMAVRDLMRS
121 IFLCDMDVFD AYMPQSRNLS AFFNWATSRA LCSPPACSAF PRGTISKQDV CKTLCTRQPF
181 SLAREACRSY SHVVLKEVRF FNLQVLYPLL SDPALNLRIV HLVRDPRAVL RSREAAGPIL
241 ARDNGIVLGT NGKWVEADPH LRLIREVCRS HVRIAEAATL KPPPFLRGRY RLVRFEDLAR
301 EPLAEIRALY AFTGLTLTPQ LEAWIHNITH GSGIGKPIEA FHTSSRNARN VSQAWRHALP
361 FTKILRVQEV CAGALQLLGY RPVYSADQQR DLTLDLVLPR GPDHFSWASP DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHST5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 82 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 82 nTPM
- small intestine: 73 nTPM
- rectum: 46 nTPM
- colon: 43 nTPM
- skeletal muscle: 6.5 nTPM
- stomach: 4.3 nTPM
Single-cell type
- colonocytes: 27 nCPM
- enterocytes: 27 nCPM
- goblet cells: 25 nCPM
- ependymal cells: 14 nCPM
- enteric transient amplifying cells: 11 nCPM
- neuroendocrine cells: 8.5 nCPM
Immune cell
- basophil: 0.7 nTPM
- neutrophil: 0.3 nTPM
- non-classical monocyte: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- eosinophil: 0.1 nTPM
- gdT-cell: 0.1 nTPM
Brain region
- choroid plexus: 8.6 nTPM
- cerebral cortex: 8 nTPM
- hippocampal formation: 8 nTPM
- medulla oblongata: 7.8 nTPM
- amygdala: 7.7 nTPM
- basal ganglia: 7.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.23
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate metabolic process
- keratan sulfate proteoglycan biosynthetic process
- N-acetylglucosamine metabolic process
- protein sulfation
- sulfur compound metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHST5 as an antibody target. Whether an autoantibody or antibody against CHST5 could matter depends on whether native CHST5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHST5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHST5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...